July 23, 2024- Owens & Minor, Inc. announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaffirmed its outlook for the full year 2024 as noted below in advance of its second quarter 2024 earnings announcement and conference call.
Selected Preliminary Financial Results for the Quarter Ended June 30, 2024 (1) | |
| ($ in millions, except per share data) | 2Q24 |
| Revenue | $2,651 – $2,671 |
| Operating income, GAAP | $16 – $20 |
| Adj. Operating Income, Non-GAAP | $72 – $76 |
| Net loss, GAAP | $(35) – $(32) |
| Adj. Net Income, Non-GAAP | $25 – $28 |
| Adj. EBITDA, Non-GAAP | $123 – $127 |
| Net loss per common share, GAAP | $(0.46) – $(0.42) |
| Adj. Net Income per share, Non-GAAP | $0.32 – $0.36 |
| Operating cash flow | $111 – $116 |
| Total debt and net debt reduction | $68 – $71 |
The Company reaffirms its outlook for the full year 2024 on a standalone basis excluding the expected impact of the Rotech acquisition.
- Revenue for 2024 to be in a range of $10.5 billion to $10.9 billion
- Adjusted EBITDA for 2024 to be in a range of $550 million to $590 million
- Adjusted EPS for 2024 to be in a range of $1.40 to $1.70
The Company’s outlook for 2024 contains assumptions, including current expectations regarding the impact of general economic conditions, including inflation, and the continuation of pressure on pricing and demand in our Products & Healthcare Services segment.